Evaluation of Repeat Administration of Purified Poloxamer 188
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety of repeat administration of MST-188
during vaso-occlusive crisis of sickle cell disease. Additionally, this study will evaluate
the development of acute chest syndrome during VOC and re-hospitalization for recurrence of
VOC.